Having trouble accessing articles? Reset your cache.

Oncimmune reports lung cancer test data

Oncimmune Ltd. (Nottingham, U.K.) said its EarlyCDT-Lung test had sensitivities of 36%,

Read the full 129 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE